Brighter

Investment summary

Brighter is a healthtech company developing solutions for chronic diseases. Its initial strategy is the market introduction of Actiste, a remote monitoring and treatment service for diabetes. The service includes a unique patented device that integrates all the essential features for daily diabetes management, a blood glucose meter, a lancer, an insulin injection pen, into a single unit with built-in mobile connection, and a digital platform for analysing and sharing data with family & friends, healthcare providers and other relevant stakeholders. The service also includes personalized home deliveries of daily consumables and continuous data-based feedback to motivate the user and stimulate increased treatment adherence. By eliminating thresholds and reducing the number of treatment steps to 9 from 28 in comparison to traditional self-blood glucose (SMBG) meters and insulin injection pens, Brighter’s goal is to promote patient behavioral change of daily insulin-dependent diabetes management for better treatment outcome.